Improvement in Antiepileptic Drug Levels Following Reduction of Intervals Between Clinic Visits

Summary: Antiepileptic drug levels (AEDLs) may reflect how well patients adhere to prescribed medical regimens. Of 30 patients on stable drug regimens AEDLs were increased in 33% by decreasing clinic visit intervals from a mean of 3.4 months to 1.1 months. The testing situation was applied to patients who had AEDLs in the “therapeutic range”(n= 15) as well as those with one or more AEDLs below “therapeutic range” (n= 15). In the latter group 73% of patients showed improvement in AEDLs. Although a less reliable parameter, verbally reported seizure frequencies were also improved. Overall, the reduction in clinic visit interval could be expected to yield improvement in 46 to 80% (confidence interval = 95%). These patients responded equally well to physician and non‐physician practitioners. This technique may be useful as an intervening measure for those patients who are noncompliant.

[1]  K J Rothman,et al.  A show of confidence. , 1978, The New England journal of medicine.

[2]  I. Leppik,et al.  COEFFICIENT OF VARIATION AS MEASURE OF COMPLIANCE , 1978, The Lancet.

[3]  C. Terrence,et al.  Phenytoin dosage in ambulant epileptic patients. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[4]  L. Marton,et al.  Determination of carbamazepine in blood or plasma by high-pressure liquid chromatography. , 1976, Clinical chemistry.

[5]  J. Penry,et al.  Usefulness of blood levels of antiepileptic drugs. , 1974, Archives of neurology.

[6]  L. Lund Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures. , 1974, Archives of neurology.

[7]  E. Solow,et al.  Antiepileptic drugs: a current assessment of simultaneous determination of multiple drug therapy by gas liquid chromatography-on column methylation. , 1974, Journal of chromatographic science.

[8]  Haerer Af,et al.  Follow-up of epileptic outpatients. , 1973 .

[9]  A. Haerer,et al.  Follow‐Up of Epileptic Outpatients , 1973, Southern medical journal (Birmingham, Ala. Print).

[10]  A. Sherwin,et al.  Improved control of epilepsy by monitoring plasma ethosuximide. , 1973, Archives of Neurology.

[11]  K. Dawson,et al.  Value of blood phenytoin estimation in management of childhood epilepsy. , 1971, Archives of disease in childhood.

[12]  A. Handley,et al.  Supervision of Epileptic Patients Taking Phenytoin , 1970, British medical journal.

[13]  J. Grace,et al.  STUDIES OF ANTICONVULSANT LEVELS IN EPILEPTICS , 1969 .

[14]  J. Haynes,et al.  Some causes of ineffectiveness of diphenylhydantoin. , 1966, Archives of neurology.

[15]  M. Lund,et al.  Serum Diphenylhydantoin (Phenytoin) in Ambulant Patients with Epilepsy , 1964, Epilepsia.